Related Experiment Video
Updated: Jan 3, 2026
Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
Targeting the P2X7 Receptor in Age-Related Macular Degeneration
1Department of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall Street, Ann Arbor, MI 48105, USA.
Abstract:
The P2X7 receptor (P2X7R) is a membrane receptor for the extracellular adenosine triphosphate (ATP). It functions as a ligand-gated non-selective cation channel and can mediate formation of a large non-selective membrane pore. Activation of the P2X7R induces multiple downstream events, including oxidative stress, inflammatory responses and cell death. Although the P2X7R has been identified in the retinal pigment epithelium (RPE) and different layers of retina, its biological and pathological functions as well as its downstream signaling pathways in the RPE and retina are not yet fully understood. Better understanding of the function of P2X7R in the RPE and retina under normal and disease states might lead to novel therapeutic targets in retinal diseases, including age-related macular degeneration (AMD). This brief review will mainly focus on recent findings on in vitro and in vivo evidence for the role of the P2X7R in the RPE and AMD.
Insights
The P2X7 receptor (P2X7R) plays a role in retinal pigment epithelium (RPE) and retina function. Understanding P2X7R in RPE and retina may reveal new therapeutic targets for age-related macular degeneration (AMD).
Area of Science:
- Ophthalmology
- Cell Biology
- Neuroscience
Background:
- The P2X7 receptor (P2X7R) is an extracellular adenosine triphosphate (ATP) receptor.
- P2X7R activation triggers oxidative stress, inflammation, and cell death.
- P2X7R is present in the retinal pigment epithelium (RPE) and retina, but its precise roles are unclear.
Purpose of the Study:
- To review recent findings on P2X7R in the RPE and its involvement in age-related macular degeneration (AMD).
- To explore the biological and pathological functions of P2X7R in the RPE and retina.
- To identify potential therapeutic targets for retinal diseases.
Main Methods:
- Review of in vitro and in vivo studies on P2X7R.
- Analysis of P2X7R signaling pathways in RPE and retinal cells.
- Examination of P2X7R's role in the pathogenesis of AMD.
Main Results:
- Evidence suggests P2X7R activation influences RPE and retinal cell function.
- P2X7R signaling pathways are implicated in inflammatory responses and cell death relevant to AMD.
- In vitro and in vivo data highlight P2X7R's contribution to retinal disease processes.
Conclusions:
- Further understanding of P2X7R in the RPE and retina is crucial for developing novel treatments.
- P2X7R represents a potential therapeutic target for age-related macular degeneration (AMD) and other retinal diseases.
- Targeting P2X7R may offer a new strategy for managing retinal pathologies.
